PLANTS

Language selector

Accessibility tools

Navigation path

Status under Reg. (EC) No 1107/2009 (repealing Directive 91/414/EEC )
Legislation Reg. (EU) No 2018/1865 Old Legislation 03/70/EC ,
Reg. (EU) No 2016/2016 ,
Reg. (EU) No 540/2011 ,
Reg. (EU) No 823/2012 ,
Reg.(EU) No 84/2018
RMS

Co-RMS
FI

UK
Risk Assessment EFSA
Category FU Review Report   Review Report 2018
  List of studies 2017
  Review Report 2003
Remarks Non renewal voted in October 2018
Withdrawal authorisations by 19 June 2019
Max period of grace: 19 March 2020


Type Candidate for Substitution (CfS) CfS - criteria two PBT criteria
Authorisation at national level
Authorised in In progress for
AT, BE, CY, CZ, DE, EE, EL, ES, FI, FR, HR, HU, IE, IT, LT, LU, LV, NL, PL, PT, RO, SE, SI, SK, UK
EU - Maximum Residue Levels (Reg. (EC) No 396/2005) (MRLs)
Legislation Annexes
  • Propiconazole (sum of isomers) (F)
    MRLs Annex II
Classification Reg. 1272/2008
Acute Tox. 4 - H302 Skin Sens. 1 - H317
Aquatic Acute 1 - H400 Aquatic Chronic 1 - H410
Toxicological information
Reference values Source Remark
ADI 0.04 EFSA  
ARfD 0.1 EFSA  
AOEL 0.1 EFSA  
Other
ADI 0.07, ARfD 0.3 JMPR 2004 
Legend
  • RMS:Rapporteur Member State
  • Co-RMS:Co-Rapporteur Member State
  • ADI:Acceptable daily intake
  • ARfD:Acute reference dose
  • AOEL:Acceptable operator exposure level